A Multicenter, Phase 2 Study Evaluating the Value of Radiotherapy in Advanced Diffuse Large B-cell Lymphoma Patients With Extranodal Involvement and Large Tumors Undergoing Immunochemotherapy for PET-CT Assessment of Complete Remission
Clinical trial NCT05874778 · UNKNOWN
Trial details
- NCT number
- NCT05874778
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2026-05-15
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.